ArticleJournal of neuroinflammation2023

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod.

Alicia Gonzalez-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.